MENU
RVMD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Revolution Medicines (RVMD) Earnings Date & Reports

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways... Show more

A.I. Advisor
published Earnings

RVMD is expected to report earnings to fall 4.97% to -152 cents per share on March 02

Revolution Medicines RVMD Stock Earnings Reports
Q4'25
Est.
$-1.53
Q3'25
Missed
by $0.20
Q2'25
Missed
by $0.19
Q1'25
Missed
by $0.04
Q4'24
Missed
by $0.13
The last earnings report on November 05 showed earnings per share of -161 cents, missing the estimate of -140 cents. With 1.43M shares outstanding, the current market capitalization sits at 12.73B.
View a ticker or compare two or three
RVMD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RVMD showed earnings on November 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

an oncology company, which focused on developing novel targeted therapies and engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
700 Saginaw Drive
Phone
+1 650 481-6801
Employees
378
Web
https://www.revmed.com